Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis

Carol Dobson-Stone, Adrian Danek, Luca Rampoldi, Richard J. Hardie, Richard M. Chalmers, Nicholas W. Wood, Saeed Bohlega, Maria Teresa Dotti, Antonio Federico, Masami Shizuka, Makoto Tanaka, Mitsunori Watanabe, Yoshio Ikeda, Mitchell Brin, Lev G. Goldfarb, Barbara I. Karp, Saidi Mohiddin, Lameh Fananapazir, Alexander Storch, Alan E. FryerPaul Maddison, Igor Sibon, Paulo C. Trevisol-Bittencourt, Carlos Singer, Ignacio Requena Caballero, Jan O. Aasly, Klaus Schmierer, Reinhard Dengler, Lutz Peter Hiersemenzel, Massimo Zeviani, Vardiella Meiner, Alexander Lossos, Sturla Johnson, Flavio C. Mercado, Giuseppe Sorretino, Nicolas Dupré, Guy A. Rouleau, Jens Volkmann, Javier Arpa, Andrew Lees, Gilles Geraud, Sylvain Chouinard, Andrea Németh, Anthony P. Monaco

Research output: Contribution to journalArticlepeer-review


Chorea-acanthocytosis (ChAc) is an autosomal recessive neurological disorder whose characteristic features include hyperkinetic movements and abnormal red blood cell morphology. Mutations in the CHAC gene on 9q21 were recently found to cause chorea-acanthocytosis. CHAC encodes a large, novel protein with a yeast homologue implicated in protein sorting. In this study, all 73 exons plus flanking intronic sequence in CHAC were screened for mutations by denaturing high-performance liquid chromatography in 43 probands with ChAc. We identified 57 different mutations, 54 of which have not previously been reported, in 39 probands. The novel mutations comprise 15 nonsense, 22 insertion/deletion, 15 splice-site and two missense mutations and are distributed throughout the CHAC gene. Three mutations were found in multiple families within this or our previous study. The preponderance of mutations that are predicted to cause absence of gene product is consistent with the recessive inheritance of this disease. The high proportion of splice-site mutations found is probably a reflection of the large number of exons that comprise the CHAC gene. The CHAC protein product, chorein, appears to have a certain tolerance to amino-acid substitutions since only two out of nine substitutions described here appear to be pathogenic.

Original languageEnglish
Pages (from-to)773-781
Number of pages9
JournalEuropean Journal of Human Genetics
Issue number11
Publication statusPublished - Nov 1 2002


  • CHAC
  • Choreacanthocytosis
  • Chorein
  • Mutational spectrum
  • Neuroacathocytosis

ASJC Scopus subject areas

  • Genetics(clinical)


Dive into the research topics of 'Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis'. Together they form a unique fingerprint.

Cite this